Trial Profile
Effect of Losartan on Airway Parameters in COPD [chronic obstructive pulmonary disease]
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Biomarker; Therapeutic Use
- 13 Aug 2008 New trial record.